Search research articles
Contact Us
Filters
Showing results (101-110 of 111) with videos related to
Page
of 12
Sort By:
Journal of Medicinal Chemistry
|
November 18, 2010
A novel pyrazolo[1,5-a]pyrimidine is a potent inhibitor of cyclin-dependent protein kinases 1, 2, and 9, which demonstrates antitumor effects in human tumor xenografts following oral administration
Dean A Heathcote, Hetal Patel, Sebastian H B Kroll, et al.
Cancer Research
|
March 21, 2020
Endonuclease FEN1 Coregulates ERα Activity and Provides a Novel Drug Interface in Tamoxifen-Resistant Breast Cancer
Koen D Flach, Manikandan Periyasamy, Ajit Jadhav, et al.
Oncotarget
|
August 18, 2015
Expression profiling of nuclear receptors in breast cancer identifies TLX as a mediator of growth and invasion in triple-negative breast cancer
Meng-Lay Lin, Hetal Patel, Judit Remenyi, et al.
Nature Communications
|
April 20, 2022
ESR1 mutant breast cancers show elevated basal cytokeratins and immune activation
Zheqi Li, Olivia McGinn, Yang Wu, et al.
Nature Communications
|
December 2, 2017
Discovery of naturally occurring ESR1 mutations in breast cancer cell lines modelling endocrine resistance
Lesley-Ann Martin, Ricardo Ribas, Nikiana Simigdala, et al.
Iscience
|
May 25, 2026
Distinct 2-phenylimidazo[1,2-<i>a</i>]pyridine derivatives that inhibit breast cancer cell proliferation identified as AHR ligands
Katrin Koellisch, Christine Blattner, Stefano Motta, et al.
JCO Precision Oncology
|
May 1, 2024
Serial Postoperative Circulating Tumor DNA Assessment Has Strong Prognostic Value During Long-Term Follow-Up in Patients With Breast Cancer
Jacqueline A Shaw, Karen Page, Evie Wren, et al.
Journal of Natural Products
|
June 20, 2025
Modulation of Estrogen Receptor Activity by the Phytoalexin Tuberosin Produced from Elicited Kudzu (<i>Pueraria lobata</i>)
Jorge A Belgodere, Jack R Elliott, Megan C Benz, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 18, 2019
Personalized Detection of Circulating Tumor DNA Antedates Breast Cancer Metastatic Recurrence
Raoul Charles Coombes, Karen Page, Raheleh Salari, et al.
Cancer Research
|
January 26, 2022
Hotspot ESR1 Mutations Are Multimodal and Contextual Modulators of Breast Cancer Metastasis
Zheqi Li, Yang Wu, Megan E Yates, et al.
Page
of 12
Search research articles
Search
Showing results (101-110 of 111) with videos related to
Sort By:
Page
of 12
Journal of Medicinal Chemistry
|
November 18, 2010
A novel pyrazolo[1,5-a]pyrimidine is a potent inhibitor of cyclin-dependent protein kinases 1, 2, and 9, which demonstrates antitumor effects in human tumor xenografts following oral administration
Dean A Heathcote, Hetal Patel, Sebastian H B Kroll, et al.
Cancer Research
|
March 21, 2020
Endonuclease FEN1 Coregulates ERα Activity and Provides a Novel Drug Interface in Tamoxifen-Resistant Breast Cancer
Koen D Flach, Manikandan Periyasamy, Ajit Jadhav, et al.
Oncotarget
|
August 18, 2015
Expression profiling of nuclear receptors in breast cancer identifies TLX as a mediator of growth and invasion in triple-negative breast cancer
Meng-Lay Lin, Hetal Patel, Judit Remenyi, et al.
Nature Communications
|
April 20, 2022
ESR1 mutant breast cancers show elevated basal cytokeratins and immune activation
Zheqi Li, Olivia McGinn, Yang Wu, et al.
Nature Communications
|
December 2, 2017
Discovery of naturally occurring ESR1 mutations in breast cancer cell lines modelling endocrine resistance
Lesley-Ann Martin, Ricardo Ribas, Nikiana Simigdala, et al.
Iscience
|
May 25, 2026
Distinct 2-phenylimidazo[1,2-<i>a</i>]pyridine derivatives that inhibit breast cancer cell proliferation identified as AHR ligands
Katrin Koellisch, Christine Blattner, Stefano Motta, et al.
JCO Precision Oncology
|
May 1, 2024
Serial Postoperative Circulating Tumor DNA Assessment Has Strong Prognostic Value During Long-Term Follow-Up in Patients With Breast Cancer
Jacqueline A Shaw, Karen Page, Evie Wren, et al.
Journal of Natural Products
|
June 20, 2025
Modulation of Estrogen Receptor Activity by the Phytoalexin Tuberosin Produced from Elicited Kudzu (<i>Pueraria lobata</i>)
Jorge A Belgodere, Jack R Elliott, Megan C Benz, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 18, 2019
Personalized Detection of Circulating Tumor DNA Antedates Breast Cancer Metastatic Recurrence
Raoul Charles Coombes, Karen Page, Raheleh Salari, et al.
Cancer Research
|
January 26, 2022
Hotspot ESR1 Mutations Are Multimodal and Contextual Modulators of Breast Cancer Metastasis
Zheqi Li, Yang Wu, Megan E Yates, et al.
Page
of 12